OrbiMed’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Buy |
+8,461,500
| New | +$19.2M | 0.48% | 42 |
|
|
2024
Q2 | – | Sell |
-3,544,578
| Closed | -$7.73M | – | 113 |
|
|
2024
Q1 | $7.73M | Buy |
+3,544,578
| New | +$7.73M | 0.14% | 89 |
|
|
2022
Q3 | – | Sell |
-2,124,975
| Closed | -$3.89K | – | 131 |
|
|
2022
Q2 | $3.89K | Hold |
2,124,975
| – | – | 0.07% | 117 |
|
|
2022
Q1 | $5.67M | Sell |
2,124,975
-1,089,534
| -34% | -$2.91M | 0.09% | 117 |
|
|
2021
Q4 | $13.9M | Buy |
3,214,509
+1,392,641
| +76% | +$6.03M | 0.18% | 104 |
|
|
2021
Q3 | $9.27M | Buy |
1,821,868
+308,700
| +20% | +$1.57M | 0.1% | 131 |
|
|
2021
Q2 | $9.58M | Buy |
+1,513,168
| New | +$9.58M | 0.1% | 125 |
|